Prostaglandin D2
Description
Description of prostaglandin D2 with associated disease summary
Disease summary
Asthma
The EBC PGD2 concentrations in asthma patients increased after allergen inhalation (J Allergy Clin Immunol. (2008)).Summary of extracted biomedical information
Associated references with human 5
Download references
Reference title
with link to reference page |
Journal | Year | Authors & PubMed Link |
---|---|---|---|
Biomarker Profiles in Asthma With High vs Low Airway Reversibility and Poor Disease Control. | Chest | 2015 |
WW. Busse, ST. Holgate, SW. Wenzel, P. Klekotka, Y. Chon, J. Feng, EP. Ingenito, A. Nirula
Chest 2015 Dec;148(6):1489-1496. PubMed:26226215 |
Prostaglandin D₂ pathway upregulation: relation to asthma severity, control, and TH2 inflammation. | J. Allergy Clin. Immunol. | 2013 |
ML. Fajt, SL. Gelhaus, B. Freeman, CE. Uvalle, JB. Trudeau, F. Holguin, SE. Wenzel
J. Allergy Clin. Immunol. 2013 Jun;131(6):1504-12. PubMed:23506843 |
Lipid metabolite levels of prostaglandin D2 and eicosapentaenoic acid recovered from bronchoalveolar lavage fluid correlate with lung function of chronic obstructive pulmonary disease patients and controls. | Electrophoresis | 2009 |
E. Csanky, R. Rühl, B. Scholtz, A. Vasko, L. Takacs, WM. Hempel
Electrophoresis 2009 Apr;30(7):1228-34. PubMed:19294692 |
Effects of a thromboxane-receptor antagonist, BAY u 3405, on prostaglandin D2- and exercise-induced bronchoconstriction. | J. Allergy Clin. Immunol. | 1992 |
H. Magnussen, S. Boerger, K. Templin, AR. Baunack
J. Allergy Clin. Immunol. 1992 Jun;89(6):1119-26. PubMed:1535083 |
Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement. | J. Clin. Invest. | 1985 |
AG. Togias, RM. Naclerio, D. Proud, JE. Fish, NF. Adkinson, A. Kagey-Sobotka, PS. Norman, LM. Lichtenstein
J. Clin. Invest. 1985 Oct;76(4):1375-81. PubMed:2414318 |
Associated curated diseases 1
Download diseasesAssociated disease mapping
Mapping of all associated diseases to prostaglandin D2 is displayed in red.
Disease Name
with link to disease page |
Description of MeSH term
with link to MeSH Database |
Number of references |
---|---|---|
Asthma |
MeSH:
Asthma
A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and
intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of
airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
Link to MeSH Database: D001249
|
91 |
Associated abnormalities 0
No associated abnormalities are detected in current reference collection.
There are 5 associated references with prostaglandin D2. Due to lack of full text of references or no associated abnormalities are detected in our text-mining workflow, we cannot extract any abnormality terms from the associated reference collection.
Associated chemicals 0
No associated chemicals are detected in current reference collection.
There are 5 associated references with prostaglandin D2. Due to lack of full text of references or no associated chemicals are detected in our text-mining workflow, we cannot extract any chemical terms from the associated reference collection.
Associated functions 0
No associated functions are detected in current reference collection.
There are 5 associated references with prostaglandin D2. Due to lack of full text of references or no associated functions are detected in our text-mining workflow, we cannot extract any function terms from the associated reference collection.
Associated genes 0
No associated genes are detected in current reference collection.
There are 5 associated references with prostaglandin D2. Due to lack of full text of references or no associated genes are detected in our text-mining workflow, we cannot extract any gene terms from the associated reference collection.
NCBI Entrez Crosslinks
Chemical Information
Formula | C20H32O5 |
Mass | 352.471 |
Synonyms | prostaglandin D2 PGD2 11-Dehydroprostaglandin F2-alpha 41598-07-6 11-Dehydroprostaglandin F2alpha BRN 2170623 [3H]PGD2 CHEBI:15555 (5Z,13E,15S)-9alpha,15-Dihydroxy-11-oxoprosta-5,13-dienoate 9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid (5Z,13E)-(15S)-9alpha,15-Dihydroxy-11-oxoprosta-5,13-dienoate Prosta-5,13-dien-1-oic acid, 9,15-dihydroxy-11-oxo-, (5Z,9-alpha,13E,15S)- (Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-3-oxocyclopentyl]hept-5-enoic acid UNII-RXY07S6CZ2 (5z,13e)-(15s)-9-alpha,15-dihydroxy-11-oxoprosta-5,13-dienoate 11-Dehydroprostaglandin F2 alpha [3H]prostaglandin D2 AC1L9LZD RXY07S6CZ2 BSPBio_001486 |
PubChem CID | 448457 |